Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Stopped This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.

Conditions

• Extensive Stage Small Cell Lung Cancer

Interventions

• DRUG: Carboplatin for injection/cisplatin for injection + etoposide injection + benmelstobart injection + Anlotinib hydrochloride capsule
• DRUG: Carboplatin for injection/Cisplatin for injection + etoposide injection + Tislelizumab injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.